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Abstract 
Background: Coagulase-negative staphylococci (CoNS) are the most common bovine mastitis causing bacteria in 
many countries. It is known that resistance for antimicrobials is in general more common in CoNS than in Staphylococ-
cus aureus but little is known about the antimicrobial resistance of specific CoNS species. In this study, 400 CoNS iso-
lates from bovine mastitic milk samples were identified to species level using ribotyping and MALDI-TOF MS, and their 
antimicrobial susceptibility was determined using a commercially available microdilution system. The results were 
interpreted according to the epidemiological cut-off values by the European Committee on Antimicrobial Susceptibil-
ity testing.
Results: The most common CoNS species were S. simulans, S. epidermidis, S. chromogenes and S. haemolyticus. Penicil-
lin resistance was the most common type of antimicrobial resistance. Staphylococcus epidermidis was the most resist-
ant among the four major species. Almost one-third of our S. epidermidis isolates were resistant to >2 antimicrobials 
and close to 7 % were multidrug resistant. The majority of S. epidermidis isolates were resistant to benzylpenicillin. On 
the contrary, only few S. simulans isolates were penicillin-resistant. Phenotypic oxacillin resistance was found in all four 
main species, and 34 % of the isolates were oxacillin resistant. However, only 21 isolates (5 %) were positive for the 
mecA gene. Of these, 20 were S. epidermidis and one S. sciuri. mecC positive isolates were not found.
Conclusion: Staphylococcus epidermidis differed from the three other major CoNS species as resistance to the tested 
antimicrobials was common, several isolates were multidrug resistant, and 19 % of the isolates carried the mecA gene 
encoding methicillin resistance.
Keywords: Coagulase-negative staphylococci, CoNS species, Antimicrobial resistance, Bovine, Cow, MIC, 
Staphylococcus epidermidis, Staphylococcus chromogenes, Staphylococcus haemolyticus, Staphylococcus simulans
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Background
Prevalence of mastitis in dairy cows and distribution of 
mastitis-causing bacteria has regularly been monitored 
in Finland [1, 2]. These surveys have also reported anti-
microbial in vitro susceptibility of different bacterial spe-
cies, including coagulase-negative staphylococci (CoNS). 
Coagulase-negative staphylococci have become the most 
common mastitis causing agents in many countries [3]. 
They mostly cause subclinical mastitis but have also been 
isolated from clinical mastitis [3, 4]. It is known that 
resistance for antimicrobials is in general more common 
in CoNS than in S. aureus [4]. The most common resist-
ance among bovine CoNS is production of β-lactamase 
which confers resistance to benzylpenicillin and ami-
nopenicillins, but also resistance towards aminoglyco-
sides, tetracyclines, and macrolides has been reported 
[2, 5, 6]. Methicillin-resistant CoNS have been isolated 
from bovine mastitis which is of special concern because 
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of the risk of spreading the mec genes [7, 8]. Further-
more, emergence of resistance among CoNS is a con-
cern because resistance determinants may be transferred 
between staphylococcal species and form a risk for public 
health [9, 10].
Phenotypic identification methods for bovine CoNS 
have proven to be unsatisfactory [11–13]. Molecular 
methods have become available for identification of 
CoNS to species level, which has made species deter-
mination more reliable. Reliable genotypic identifica-
tion has enabled studying frequency of different CoNS 
species and species-specific antimicrobial susceptibil-
ity. Reports on mastitis causing CoNS species and their 
antimicrobial susceptibility have since been published 
by some authors [5, 6, 14]. Unfortunately, only few stud-
ies have used epidemiological cut-off values (ECOFF) of 
the European Committee on Antimicrobial Susceptibility 
testing to determine proportions of resistant isolates [15], 
which has made comparisons difficult. Studies on genetic 
mechanisms for resistance of bovine CoNS species have 
also been published, with different panels of resistance 
genes [5, 16, 17]. In Finland, antimicrobial susceptibility 
of CoNS has been reported for bovine CoNS as a group 
only [2, 18]. It is likely that in the future CoNS will no 
more be considered as one homogenous group, but spe-
cies-specific approaches become possible in mastitis con-
trol [3]. Knowledge on the antimicrobial susceptibility of 
different CoNS species is then also necessary.
The aim of this study was to explore the distribution of 
CoNS species isolated from mastitic milk samples in Fin-
land and to determine the antimicrobial susceptibility of 
different CoNS species.
Methods
The material consists of CoNS isolates from two studies, 
Pitkälä et  al. [2] (dataset 1) and Finnish veterinary anti-
microbial resistance monitoring program 2010–2012 [18] 
(dataset 2). The number of CoNS isolates was 312 and 88 
in dataset 1 and 2, respectively.
The first study (dataset 1) was a nationwide prevalence 
study carried out in 2001, in which milk samples were 
collected from all four quarters of all lactating cows in 
herds randomly allocated into the study. Conventional 
microbiological methods were used to identify bacteria 
isolated from the milk samples [2, 19]. The milk sam-
ples were classified as mastitic when the milk somatic 
cell count, measured with an electric counter (Fosso-
matic Milk Analysis, Foss Electric, Hillerød, Denmark), 
exceeded 300 000 cells/ml. Of the total of 2103 CoNS iso-
lated in that study, 335 were randomly chosen for in vitro 
antimicrobial susceptibility testing [2]. Of these isolates, 
318 were successfully identified to species level in the 
present study. Six isolates appeared to belong to S. aureus 
species and were withdrawn from this study. In the sec-
ond study (dataset 2) the samples were routine mastitis 
samples (based on elevated milk somatic cell count and/
or clinical signs of mastitis) submitted during 2012 to the 
laboratory of Valio Ltd by veterinarians and dairy farm-
ers. Bacteriological etiology of mastitis was determined 
by a real-time PCR assay (Thermo Scientific PathoProof™ 
Mastitis Complete-12 Kit, Thermo Fisher Scientific 
Ltd.,Vantaa, Finland). During the study, the preservative 
was left out from the milk tubes. Samples positive for 
CoNS in the PCR test were selected for culture. From 
the cultured pure samples the first cultured 88 CoNS 
isolates, but only one isolate per herd, were selected for 
determination of antimicrobial susceptibility. Staphylo-
coccus species identification was performed during the 
present study.
The CoNS isolates from both datasets were identified 
to species level with the 16S and 23S rRNA gene restric-
tion fragment length polymorphism method (ribotyp-
ing) as described previously [20]. The CoNS species were 
determined by comparison in a numerical similarity anal-
ysis of the ribotype patterns with a ribotype library using 
BioNumerics 5.1 software package (Applied Maths, St.-
Martens-Latem, Belgium). For some isolates ribotyping 
failed, and they were later analyzed with MALDI-TOF 
MS (Microflex LT, Bruker Daltonic Gmbh, Bremen, Ger-
many). The correctness of species identification based 
on ribotyping was confirmed by analyzing a representa-
tive sample of all different ribotype patterns by MALDI-
TOF MS [21]. The agreement between the methods was 
excellent.
Antimicrobial susceptibility of CoNS isolates from 
both datasets was determined in the previous stud-
ies [2, 18] using a commercially available microdilution 
system (VetMIC™; SVA, Uppsala, Sweden). Minimum 
inhibitory concentrations (MIC) in both datasets were 
determined for penicillin, cephalothin, oxacillin, eryth-
romycin, chloramphenicol, clindamycin, tetracycline, 
gentamicin, neomycin, streptomycin, and trimethoprim/
sulfamethoxazole. In addition, MICs for virginiamycin, 
vancomycin and avilamycin in dataset 1, and for fusidic 
acid, kanamycin, ciprofloxacin, trimethoprim, florfenicol, 
and cefoxitin in dataset 2, were determined. Results from 
the susceptibility testing were interpreted according to 
the epidemiological cut-off values (ECOFFs) by the Euro-
pean Committee on Antimicrobial Susceptibility testing 
(EUCAST) [22] as non-wild type (from now on referred 
as resistant) or wild type (sensitive). If a specific ECOFF 
was not available for the specific species or for CoNS 
as a group, ECOFF of Staphylococcus aureus was used. 
Production of beta-lactamase was tested using nitroce-
fin discs (dataset 1: AB Biodisk, Solna Sweden; dataset 
2: Becton–Dickinson, NJ, USA). The isolates with MIC 
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values for oxacillin  >1  mg/l were tested for presence of 
the mecA gene in dataset 1 and for presence of the mecA 
and mecC genes in dataset 2, using PCR and primers 
reported previously [23, 24].
Results
Distribution of CoNS species
The numbers and proportions of isolates of different 
CoNS species are shown in Table 1. In dataset 1, a total of 
14 staphylococcal species were identified. The most com-
mon CoNS species were S. simulans (25.0 %), S. epider-
midis (25.0 %), S. chromogenes (15.4 %), S. haemolyticus 
(11.9 %), and S. warneri (10.3 %). Three isolates could not 
be identified by ribotyping or by MALDI-TOF MS and 
were grouped as Staphylococcus sp. In dataset 2, similarly 
as in the dataset 1, S. simulans (34.1 %) and S. epidermidis 
(30.7 %) were the most common species. Staphylococcus 
chromogenes was the third most common species (6.8 %). 
The proportion of both S. haemolyticus and S. cohnii 
isolates was 5.7 %. Three isolates could not be identified 
by ribotyping or MALDI-TOF MS and were grouped as 
Staphylococcus sp. The unidentified isolates may rep-
resent a new Staphylococcus species or one of the few 
CoNS species, like S. devriesei, which were not included 
in the ribotype and MALDI-TOF MS comparison data-
bases at the time of the analyses. The four most common 
CoNS species represented 77.3 % of all 400 isolates.
In vitro antimicrobial susceptibility
The four major CoNS species differed in their in  vitro 
antimicrobial susceptibility. Among them, antimicrobial 
resistance was most common in S. epidermidis (Tables 2 
and 3). MIC distributions of the four major CoNS species 
for the tested antimicrobials in 2001 and 2012 are shown 
in Tables 2 and 3. The MIC results of all 400 isolates by 
species are shown in the Additional file 1: Table S1 and as 
a CoNS group in the Additional file 2: Table S2.  
The majority, 74.4 and 74.1  % of S. epidermidis iso-
lates in years 2001 and 2012, respectively, were resistant 
to benzylpenicillin (ECOFF 0.125  mg/l). Resistance to 
benzylpenicillin was also common in S. haemolyticus of 
which 64.9/40.0  % were resistant. Prevalence of isolates 
producing betalactamase, i.e. positive in the nitrocefin 
test, varied between CoNS species, and was lower in S. 
chromogenes (20.8/16.7  %) and S. simulans (3.9/6.7  %) 
than in S. epidermidis (59.0/70.4  %) and S. haemo-
lyticus (51.4/0.0  %). Combining years 2001 and 2012, 
a total of 165 of the total of 400 isolates (41.3  %) had a 
MIC > 0.125 mg/l for benzylpenicillin i.e. were penicillin-
resistant. In the nitrocefin test, 137 (34.3 %) isolates out 
of 400 were positive (penicillin resistant). Out of 165 iso-
lates with MIC for > 0.125 mg/l for benzylpenicillin, 127 
(77.0 %) isolates were positive in the nitrocefin test (true 
positive), and 38 were negative (false negative). Out of 
235 isolates with MIC ≤ 0.125 mg/l for benzylpenicillin, 
Table 1 Distribution of  coagulase-negative Staphylococcus species isolated in  bovine milk samples in  2001 (dataset 1) 
and 2012 (dataset 2)
The material consisted of CoNS isolates from two studies, Pitkälä et al. [2] (dataset 1) and Finnish veterinary antimicrobial resistance monitoring program 2010–2012 
[18] (dataset 2). In dataset 1 all quarters of cows were sampled in a mastitis survey, in dataset 2 samples originated from quarters with mastitis
CNS species 2001 2012 In total
n % n % n %
S. agnetis 7 2.2 3 3.4 10 2.5
S. capitis 1 0.3 1 1.1 2 0.5
S. chromogenes 48 15.4 6 6.8 54 13.5
S. cohnii 7 2.2 5 5.7 12 3.0
S. epidermidis 78 25.0 27 30.7 105 26.3
S. equorum 3 1.0 0 0 3 0.8
S. haemolyticus 37 11.9 5 5.7 42 10.5
S. hyicus 4 1.3 1 1.1 5 1.3
S. kloosii 0 0 3 3.4 3 0.75
S. pasteuri 2 0.6 0 0 2 0.5
S. saprophyticus 2 0.6 1 1.1 3 0.8
S. sciuri 2 0.6 1 1.1 3 0.8
S. simulans 78 25.0 30 34.1 108 27.0
S. warneri 32 10.3 1 1.1 33 8.3
S. xylosus 8 2.6 2 2.3 10 2.5
Staphylococcus sp. 3 1.0 2 2.3 5 1.3
In total 312 88 400
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225 isolates (95.7 %) were negative in the nitrocefin test 
(true negative), and 10 isolates were positive (false posi-
tive). The positive predictive value of the nitrocefin test in 
relation to penicillin resistance determined based on the 
MIC value of the isolate was 92.7 and the negative pre-
dictive value 85.6.
Considerable proportions of S. epidermidis were 
resistant to tetracycline (46.2/25.9  %) and streptomy-
cin (21.8/7.4  %) (years 2001/2012). In the other species 
this resistance was rare (Tables  1, 2). Oxacillin resist-
ance (conferring resistance also to methicillin), using 
ECOFF of 1.0 mg/l, was found in all the four main species 
(Tables 2, 3). Combining years 2001 and 2012, a total of 
137 isolates (34.3  %) were oxacillin resistant. The mecA 
gene was detected in 16 S. epidermidis isolates (20.5 %) 
from the year 2001 and in four S. epidermidis isolates 
(14.8 %) from the year 2012, and in the one S. sciuri iso-
late. Isolates harboring mecC were not found. Resistance 
to trimethoprim, measured only in dataset 2, was most 
common in S. simulans and S. haemolyticus, but the 
number of isolates of the latter species was low (Table 3). 
Staphylococcus epidermidis was the only species show-
ing resistance to cefoxitin using the ECOFF of S. aureus 
(4 mg/l) (Table 3). Resistance to fusidic acid was common 
in all other species but S. haemolyticus (Table 3). One S. 
simulans isolate was resistant to vancomycin, using the 
specific ECOFF (4 mg/l) for that species (Table 2).
Combining datasets 1 and 2, a total of 44.4 % of S. chro-
mogenes, 23.8 % of S. haemolyticus, 45.4 % of S. simulans 
and 16.2 % of S. epidermidis isolates were susceptible to 
all antimicrobials tested. Resistance to more than one 
antimicrobial was most common in S. epidermidis iso-
lates. Close to one-third (28.6  %) of them were resist-
ant to  >2 antimicrobials. Among the other three major 
species, one S. chromogenes isolate, one S. haemolyticus 
isolate, and five S. simulans isolates (4.6  %) were resist-
ant to >2 substances. Seven S. epidermidis isolates (6.7 %) 
were multidrug-resistant (MDR = resistant to 3 or more 
classes of antimicrobials); one isolate was resistant to five 
different antimicrobial classes. Among the other species, 
only one MDR S. simulans isolate was found.
Discussion
The most common CoNS species in our data, S. simu-
lans, S. epidermidis, S. chromogenes, and S. haemolyticus, 
belong to the CoNS species reported most frequently in 
numerous studies on bovine intramammary infection 
(IMI) or mastitis. Staphylococcus chromogenes has been 
isolated most commonly in almost all studies [11–13, 25–
29]. It is much more common in primiparous than mul-
tiparous cows [11, 28, 30], with peak occurrence around 
the first calving [4]. Staphylococcus chromogenes seems to 
be present in all herds [26–29] and has been frequently 
isolated not only from milk but also from bovine teat skin 
and orifice and from other body sites of heifers and cows 
[20, 31]. Staphylococcus simulans and S. epidermidis are 
common causes of IMI in some herds but not found or 
only occasionally found in some other herds [26, 27, 29, 
30, 32]. Both S. epidermidis and S. simulans are reported 
to be more common in IMIs of multiparous than primi-
parous cows [11, 28, 30]. For some reason, S. simulans is 
common in the Nordic countries [11, 12, 33] but not so 
much in Middle European countries [12, 25, 26]. Staphy-
lococcus xylosus is commonly reported in Dutch and Bel-
gian studies [13, 26, 27] but is rare in Finland, Norway 
and Sweden [6, 11, 28]. Staphylococcus haemolyticus is 
a fairly common finding in many studies [11, 13, 26–29]. 
The reasons for variable proportions of CoNS species 
isolated from dairy cattle in different countries and indi-
vidual herds are not fully elucidated but are likely related 
to different environmental conditions and herd manage-
ment [10, 31].
In the present study, genotypic identification of CoNS 
species and species-specific or CoNS-specific EUCAST 
ECOFFs when available were used. In only few other 
studies species-specific identification and the same cut-
offs than here have been used [5, 6]. In a Swedish study, 
prevalence of resistant isolates in the four major CoNS 
species was substantially lower than here [6]. Our results 
agree with them in that the most common resistance was 
to benzylpenicillin, but proportion of resistant isolates 
was clearly lower in the Swedish study. Only one out of 
34 Swedish S. epidermidis isolates was resistant to oxacil-
lin and harboured the mecA gene. In a Swiss study [5], 
oxacillin resistance was the most common resistance 
phenotype. They found as much as 47.0 % of the isolates 
(all CoNS together) to be oxacillin resistant, but the cut-
off used was two dilutions lower (0.25  mg/l) than the 
current EUCAST ECOFF, which explains the discrep-
ant results. The mecA gene was present in 9.7  % of the 
isolates classified as oxacillin-resistant. In the study by 
Frey et al. [5] the total proportion of penicillin-resistant 
isolates was lower (23.3  %) than in our study, using the 
same ECOFF, but the selection of CoNS species was dif-
ferent from ours. Results from the nitrocefin test were 
compared with results based on the penicillin MIC val-
ues of the isolates. The nitrocefin test performed better in 
detecting penicillin susceptible CoNS isolates; of isolates 
with MIC for benzylpenicillin  >0.125  mg/l, considered 
as resistant, 23 % were negative in the test. These results 
agree with the study by Pitkälä et al. [34] comparing dif-
ferent betalactamase tests, who found no false positive 
but some false negative results for blaZ positive CoNS 
using nitrocefin disk test. In testing bovine S. aureus iso-
lates, nitrocefin test has been found to be very reliable 
[34, 35]. Frey et al. [5] carried out in vitro betalactamase 
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testing with pre-incubation with benzylpenicillin but 
did not report the results, so we cannot compare them 
with ours. Interpreting results of bovine CoNS isolates 
from nitrocefin disk assay is challenging, as the color 
change is sometimes slow and not clear (Suvi Nykäse-
noja, Evira, personal communication). The performance 
of the nitrocefin tests may not be fully satisfactory in 
detecting penicillin resistance of bovine CoNS. This is of 
practical importance because nitrocefin tests are widely 
used to predict betalactamase production of bovine 
staphylococci.
Staphylococcus epidermidis was the most resistant 
among the four major species identified. Almost one-
third of our S. epidermidis isolates were resistant to  >2 
antimicrobials and close to 7 % were MDR, which were 
not found among the other species. This agrees with pre-
vious studies which also have reported S. epidermidis 
being frequently resistant to several antimicrobials [5, 
36]. The most common combination was resistance to 
penicillin and tetracycline. All mecA positive isolates, 
except one mecA positive S. sciuri isolate, were S. epi-
dermidis. However, phenotypic methicillin (oxacillin) 
resistance was also common in the other CoNS species. 
Among the other three major species, MIC values to 
oxacillin in the methicillin-resistant isolates were mainly 
only one step higher than ECOFF and did not form a dis-
tinctly different population with clearly higher MIC val-
ues. According to many studies, methicillin-resistance 
is much more common in S. epidermidis than in other 
CoNS species [8, 36–38]. Among clinical S. epidermidis 
isolates from humans, 75–90  % are resistant to methi-
cillin (reviewed by Otto [39]). Staphylococcus epider-
midis differs from other mastitis causing CoNS in many 
aspects. It is a well-known human pathogen which causes 
nosocomial infections often associated with medical 
devices [39, 40]. Staphylococcus epidermidis has a selec-
tion of virulence characteristics which include biofilm 
formation and antimicrobial resistance [3, 40]. It has 
been suggested that bovine S. epidermidis may origi-
nate from humans [38, 41]. A Finnish study did not find 
bovine methicillin-resistant S. epidermidis strains being 
closely related to human isolates [8].
Nearly all S. simulans isolates were resistant to tri-
methoprim. No specific ECOFF is available for this anti-
microbial, and we used that of S. aureus. The MICs of 
trimethoprim of most S. simulans isolates were several 
steps above the ECOFF used, which indicates true resist-
ance. More than one-third of S. epidermidis and S. simu-
lans were resistant to fusidic acid according to ECOFF for 
CoNS. Looking at the MIC distributions of our isolates, 
this ECOFF seemed not optimal for this group of CoNS. 
In a Norwegian study, 10 % of bovine CoNS isolates were 
resistant to fusidic acid using the same ECOFF, but all 
isolates classified as resistant had MIC values several 
steps over the cut-off [42]. In some CoNS species resist-
ance is more common (Table  2). Almost half of S. epi-
dermidis isolates of human origin have been resistant to 
fusidic acid and harbored the same horizontally acquired 
resistance determinants than reported in S. aureus [43].
Antimicrobial resistance among bovine CoNS isolates 
causes two types of concerns. First, it decreases options 
for antimicrobial treatment of mastitis as well as response 
to treatment. Mastitis caused by CoNS is mostly subclini-
cal or mild clinical and routine treatment is not recom-
mended [4]. In cases where treatment is warranted, 
resistance to benzylpenicillin is an issue at least in coun-
tries where penicillin or aminopenicillins are the drugs of 
choice [4]. Penicillin resistance of three of the four major 
CoNS species was here at so high level that penicillin can 
no more be considered as the first treatment option in 
mastitis caused by these species. Another option could be 
macrolides to which some degree of resistance was also 
found, in particular among S. epidermidis isolates. Preva-
lences of oxacillin resistant isolates were alarmingly high 
in all four major species. Cloxacillin is commonly used to 
treat mastitis, also mastitis caused by CoNS, so this is of 
practical relevance. If the causing CoNS strain harbors a 
mec gene, treatment with any betalactam antimicrobial is 
inefficient and only increases selection pressure.
The second concern is related to public health: cows 
can pass resistant CoNS to humans via direct contact or 
indirectly [37]. Bovine CoNS can also act as a reservoir 
for resistance determinants [3, 44]. The greatest concern 
is methicillin-resistance which was common in bovine 
CoNS and presents a relevant risk for public health [38, 
40]. There is evidence for transfer of resistance deter-
minants between staphylococcal species and also from 
CoNS to the more pathogenic species S. aureus [9, 44–
46]. Regarding critically important antimicrobials [47] 
included in the present study, the situation was good as 
only one CoNS isolate (S. simulans) was resistant to van-
comycin and no isolates to ciprofloxacin.
Unfortunately specific ECOFFs are not yet available for 
all CoNS species, and we had to use those of S. aureus for 
several antimicrobials. EUCAST ECOFFs are not veteri-
nary specific but isolates originate from multiple sources 
and perhaps mainly from humans. Most studies on anti-
microbial resistance of CoNS have used CLSI (Clinical 
and Laboratory Standards Institute) [48] breakpoints for 
veterinary pathogens. CLSI breakpoints are aimed for 
clinical purposes only [48]. They are derived from animal 
specific microbiological, pharmacokinetic and pharmaco-
dynamic data, which is not relevant for studies on in vitro 
susceptibility of epidemiological data sets [15]. Further-
more, animal specific breakpoints are not available for all 
antimicrobials and those based on human data have been 
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used [48]. CLSI documents do not give specific break-
points for bovine CoNS, but some breakpoints are avail-
able for S. aureus. In general, CLSI breakpoints are higher 
than EUCAST ECOFFs. Studies which have used different 
breakpoints for resistance cannot be compared. After phe-
notypic screening of antimicrobial resistance, as done here, 
the next step would be to study the genetic mechanisms 
for resistance. For many antimicrobials several genes can 
code for resistance in staphylococci, and new genes are 
discovered [44, 45]. Selection of a representative panel of 
resistance genes for genotypic studies is challenging.
Conclusions
The most common CoNS species were S. simulans, S. 
epidermidis, S. chromogenes, and S. haemolyticus. Staphy-
lococcus epidermidis differed from the three other most 
common CoNS species isolated from mastitic bovine 
milk samples as resistance to most tested antimicrobials 
was more common in S. epidermidis than in S. chromo-
genes, S. haemolyticus or S. simulans. Except one S. sciuri 
isolate, all mecA gene positive isolates were S. epider-
midis. Resistance to more than two antimicrobials was 
also common in S. epidermidis.
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